1. Protease inhibitors potentiate chemotherapy-induced neutropenia
by Mark Bower, Neil McCall-Peat, Natalie Ryan, Liz Davies, Anne Marie Young, Srirupa Gupta, Mark Nelson, Brian Gazzard, and Justin Stebbing
Blood
Volume 104(9):
November 1, 2004
©2004 by American Society of Hematology

2. Survival after HAART. (A) Kaplan-Meier overall survival duration curves comparing patients treated with and without a PI as part of concomitant HAART therapy. χ2 = 1.176; DF = 1; P =
Survival after HAART. (A) Kaplan-Meier overall survival duration curves comparing patients treated with and without a PI as part of concomitant HAART therapy. χ2 = 1.176; DF = 1; P = (B) Kaplan-Meier disease-free survival curves comparing patients treated with or treated without a PI as part of concomitant HAART therapy. χ2 = .108; DF = 1; P =
Mark Bower et al. Blood 2004;104:
©2004 by American Society of Hematology